Galway medtech company raises over €20m for new stroke treatment - Members' News - Week 07 - 2022
Feb 18, 2022,
by Fionnuala Malone - Category: Members' News
Welcome to GS1 Ireland members' news for week 07 2022. This week, a Galway medtech company raises over €20m for new stroke treatment. Read on for more.
Velo Coffee Roasters signs new two-year deal with Aldi
GS1 Ireland member, Velo Coffee Roasters has signed a new two-year deal to supply Aldi’s 149 Irish stores with ground coffee. As part of the new agreement, Velo Coffee’s award-winning Velo Tandem Coffee will be rebranded under Aldi’s premium Specially Selected range, as Velo Specially Selected. The deal will see Velo supply Aldi with around half a million bags of coffee over the next two years. Velo began working with Aldi in 2018, as part of Grow with Aldi, an initiative developed in partnership with Bord Bia, designed to help small and medium producers develop their brands, with the opportunity to become a core listing in all Aldi stores nationally. Aldi reports that it spent €1 billion with its Irish suppliers in 2021. Last year, GS1 Ireland interviewed Suzanne Casey of Velo Coffee Roasters about the company which you can listen to on our podcast, SCANtalk by GS1 Ireland here.
This information came from Checkout.
New Members this week at GS1 Ireland
The companies below joined GS1 Ireland since our last Members News. We would like to take this opportunity to welcome them to the GS1 Ireland community.
SIOG Botanicals - "Small artisan producer of dried flower bouquets, flower presses & natural candles. Handmade in Ireland"
Kiss Products Europe - "Kiss is the world's largest manufacturer and supplier of professional quality nail products."
Nua Bia - "NUA BIA is on a mission to build Not-Meat directly from plants and in doing so, save the world"
Suirsafe Technologies - "Suirsafe Technologies offers you perfect solutions for PPE, Medical and Cleanroom disposable products."
Cotter Farm Produce
Perfuze raises over €20m for new stroke treatment
Galway-based medtech company Perfuze has raised €22.5 million in funding for the development of an innovative treatment for acute ischemic stroke. Founded in 2018, Perfuze is developing catheter-based technology to facilitate fast clot removal during strokes. According to the WHO, stroke is the second leading global cause of death and a leading cause of disability. Perfuze’s technology aims to provide better clinical outcomes with shorter procedural times. The new round brings to €25.5 million the total funding raised to date. LSP, one of Europe’s largest healthcare investment firms and Dublin-based venture capital firm Seroba Life Sciences and SV Health invested in the latest funding round. Proceeds from the financing will go towards the next stage of the US clinical study, regulatory clearance of Perfuze’s 'Millipede System' as well as the development of new products. Perfuze expects to double its current headcount by the end of 2023.
This information came from The Irish Times.
HealthBeacon adds HSE and NHS to its client base
ealthBeacon, a Dublin based company developing products for managing injectable medications for patients in the home added five new major clients to its base including two programmes run by the HSE as well as the UK’s National Health Service (NHS). These additions will strengthen the company’s client base which now includes Amryt, Novartis, NHS, HSE, Sanofi, Accord Healthcare, Clonmel Healthcare, Teva, Viatris, and AbbVie.
This information came from Independent.ie.
FoodMarble launches its second-generation digestive breath tester
FoodMarble a Dublin company leading the way in consumer-facing gastroenterology care, has just launched the second version of its personal digestive breath tester, AIRE 2. Those suffering from digestive issues such as SIBO (Small Intestinal Bacterial Overgrowth) or IBS (Irritable Bowel Syndrome) can use this device at home to measure and monitor their digestion in real-time to help better manage their digestive health. The technology can help people to identify the particular foods that exacerbate their health issues. A clinical trial on the product is currently taking place at John Hopkins Medicine which is demonstrating the benefits of remotely monitoring levels of hydrogen and methane in the breath after eating using FoodMarble technology. AIRE 2 launched on February 8th on the FoodMarble website for €229 and will be rolling out to Amazon.com in the spring.
This information came from Irish Tech News.
That's it for this week, be sure to come back next week for more news from GS1 Ireland members around the country. If you are a GS1 Ireland member and you have some news you would like to share, please get in touch at marketing@gs1ie.org, we would love to hear from you.
Tags: Members' News